- Overview of Multidrug-Resistant Pseudomonas aeruginosa and Novel Therapeutic ApproachesMarilyn Porras-Gómez; José Vega-Baudrit; Santiago Núñez-CorralesJournal of Biomaterials and Nanobiotechnology, 2012, 03(04): 519-527.
- Assessment of Susceptibility, Pharmacodynamics, and Therapeutic Response for Interpretation of Piperacillin-Tazobactam in Vitro Activity in the Treatment of Pseudomonas aeruginosa InfectionToni-Marie, Gonzalzles; Mira, Suseno; Joseph M., Gaydos; Paul C., Schreckenberger; Carrie, Sincak; Maitry S., Mehta; Lance R., PetersonOpen Journal of Medical Microbiology, 2012, 02(03): 101-109.
- Factors influencing the acquisition and eradication of early Pseudomonas aeruginosa infection in cystic fibrosisLindsay, Jackson; Valerie, WatersJournal of Cystic Fibrosis, 2021, 20(1): 8-16.
期刊论文
Environmental risks of Pseudomonas aeruginosa–What to advise patients and parents
24阅读
